Initial results of the management of aortoiliac aneurysms with GORE® Excluder® Iliac Branched Endoprosthesis.

医学 外科 髂内动脉 动脉瘤 放射科 腔内修复术 死亡率 血管造影 髂总动脉 计算机断层血管造影 超声波 腹主动脉瘤
作者
S Schönhofer,Richard Mansour,Reza Ghotbi
出处
期刊:PubMed 卷期号:56 (6): 883-8 被引量:4
链接
标识
摘要

We prospectively observed the outcomes of all patients (N.=15) with an aortoiliac and a common iliac artery aneurysm who were electively treated with the GORE® Excluder® Iliac Branched Endoprosthesis (IBE) with regard to clinical, anatomical and radiological results.We evaluated operative mortality, aneurysm rupture rate and aneurysm related mortality as well as conversion to open surgery, incidence of endoleak, rate of aneurysm migration, aneurysm enlargement, graft patency, reintervention rate and the clinical outcome. Postoperative follow-up included a computed tomography angiography (CTA) before discharge, clinical evaluation and Duplex ultrasound or CTA 3 weeks after the intervention and Duplex ultrasound every 3 months afterwards.Mean patient age was 79 years (range 61-83 years); f/m: 1/2; mean follow-up was 9 months; 80% of the patients presented 2 or more major comorbidities and 1/3 were considered to be not eligible for open repair. Mean hospitalization time was 5 days. Technical success rate was 93.3% (intent-to-treat basis). Mortality within 30 days was 0%; there were no ruptures; type II endoleak directly after the procedure occurred in 20%, dropping to 13.3% after 3 months. We defined the initial technical success in absence of type I endoleaks. The initial technical success rate was 100%. No IBE occlusion or type Ia, Ib or III endoleak was observed during the postoperative follow-up (mean follow-up: 9 months). All of the internal iliac side branches remained patent. Reintervention rate, buttock claudication rate and pelvic complication rate were 0%.The GORE® IBE provides a new and safe alternative for the management of complete endovascular repair of an extensive aortoiliac or common iliac aneurysm while maintaining pelvic blood flow in iliac branched devices. Due to the lower complexity if compared to previous endovascular or hybrid methods, it should be performed in every anatomically suitable case.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
isonomia完成签到,获得积分10
刚刚
神秘面筋男完成签到,获得积分10
1秒前
zl739860884完成签到 ,获得积分10
1秒前
刘肖完成签到,获得积分10
1秒前
小二郎应助拼搏的问玉采纳,获得10
2秒前
务实的绝悟完成签到,获得积分10
2秒前
青青草完成签到,获得积分10
3秒前
tramp应助1111采纳,获得10
3秒前
阿飞完成签到,获得积分10
4秒前
司空悒完成签到,获得积分0
5秒前
不知道完成签到,获得积分10
5秒前
易安完成签到,获得积分10
5秒前
zero完成签到,获得积分10
6秒前
6秒前
可耐的紫夏完成签到,获得积分10
6秒前
Bryce完成签到 ,获得积分10
6秒前
李睿完成签到,获得积分10
7秒前
duanhuiyuan应助科研通管家采纳,获得10
7秒前
英俊的铭应助科研通管家采纳,获得10
8秒前
风中的丝袜完成签到,获得积分10
8秒前
汉堡包应助科研通管家采纳,获得10
8秒前
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
8秒前
DI发布了新的文献求助10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
充电宝应助科研通管家采纳,获得10
8秒前
夜白应助科研通管家采纳,获得20
8秒前
淡淡的雪应助科研通管家采纳,获得10
8秒前
8秒前
duanhuiyuan应助科研通管家采纳,获得10
8秒前
丿淘丶Tao丨完成签到,获得积分10
9秒前
9秒前
9秒前
欢喜念双完成签到,获得积分10
10秒前
纪智勇完成签到,获得积分10
11秒前
11秒前
吐泡泡的奇异果完成签到,获得积分10
11秒前
无欲无求傻傻完成签到,获得积分10
11秒前
别不开星完成签到,获得积分10
12秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
Pathology of Laboratory Rodents and Rabbits (5th Edition) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3816002
求助须知:如何正确求助?哪些是违规求助? 3359464
关于积分的说明 10402883
捐赠科研通 3077360
什么是DOI,文献DOI怎么找? 1690292
邀请新用户注册赠送积分活动 813716
科研通“疑难数据库(出版商)”最低求助积分说明 767743